MENU
+Compare
SYNB
ETF ticker: NYSE ARCA
AS OF
Sep 25 closing price
Price
$28.87
Change
-$0.50 (-1.70%)
Net Assets
5.15M

SYNB stock forecast, quote, news & analysis

The investment seeks long term capital appreciation... Show more

Category: #Health
SYNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for SYNB with price predictions
Sep 25, 2025

Momentum Indicator for SYNB turns negative, indicating new downward trend

SYNB saw its Momentum Indicator move below the 0 level on September 17, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 48 similar instances where the indicator turned negative. In of the 48 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for SYNB turned negative on September 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 24 similar instances when the indicator turned negative. In of the 24 cases the stock turned lower in the days that followed. This puts the odds of success at .

SYNB moved below its 50-day moving average on September 24, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SYNB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 50-day moving average for SYNB moved above the 200-day moving average on August 29, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

SYNB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 143 cases where SYNB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Alphabet (NASDAQ:GOOGL), Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), ZOETIS (NYSE:ZTS), Regeneron Pharmaceuticals (NASDAQ:REGN), DuPont de Nemours (NYSE:DD), Biogen (NASDAQ:BIIB), Exact Sciences Corp (NASDAQ:EXAS).

Industry description

The investment seeks long term capital appreciation. The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on “biology revolution” companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.

Market Cap

The average market capitalization across the Putnam BioRevolution ETF ETF is 240.67B. The market cap for tickers in the group ranges from 344.21M to 4.33T. NVDA holds the highest valuation in this group at 4.33T. The lowest valued company is RCKT at 344.21M.

High and low price notable news

The average weekly price growth across all stocks in the Putnam BioRevolution ETF ETF was 24%. For the same ETF, the average monthly price growth was 22%, and the average quarterly price growth was 81%. SAN experienced the highest price growth at 1%, while ICLR experienced the biggest fall at -9%.

Volume

The average weekly volume growth across all stocks in the Putnam BioRevolution ETF ETF was 5%. For the same stocks of the ETF, the average monthly volume growth was -3% and the average quarterly volume growth was -10%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 71
Price Growth Rating: 56
SMR Rating: 68
Profit Risk Rating: 70
Seasonality Score: -37 (-100 ... +100)
View a ticker or compare two or three
SYNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Putnam ETF Trus100 FEDERAL STREET
Phone
6177601060
Web
N/A